ANTOFANTOFOTC
Loading
EBITDA Over TimeStable
Percentile Rank45
3Y CAGR-15.9%
5Y CAGR+1.2%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-15.9%/yr
vs +11.9%/yr prior
5Y CAGR
+1.2%/yr
Recent deceleration
Acceleration
-27.9pp
Decelerating
Percentile
P45
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
2025$99.01B+27.9%
2024$77.40B-34.0%
2023$117.31B-29.6%
2022$166.68B+25.1%
2021$133.19B+43.1%
2020$93.08B-7.7%
2019$100.88B-5.0%
2018$106.18B-8.4%
2017$115.87B+18.1%
2016$98.14B-